💊 CBD & Cannabis Cancer Research

Cannabinoids, the active compounds found in cannabis and CBD products, are increasingly being studied by researchers as potential adjunctive treatments for managing cancer-related symptoms. While cannabis has been used traditionally for centuries, modern scientific investigation is now examining how cannabinoids may help address specific challenges faced by cancer patients, including nausea, pain, appetite loss, and sleep disturbances. The current state of research shows promising preliminary findings, though most studies are still in early to mid-stage clinical trials, and cannabinoids are not approved by the FDA as cancer treatments themselves.

As a supplement and nutraceutical category, CBD and cannabis products represent a rapidly evolving area of cancer supportive care research. Patients and caregivers are increasingly curious about these options as complementary approaches alongside conventional cancer treatment. However, it's important to understand that while some research suggests potential benefits for symptom management, cannabinoid therapy should only be pursued under medical supervision, as these compounds can interact with cancer medications and affect individual responses to treatment.

This page compiles the latest peer-reviewed research and clinical studies examining cannabinoids in cancer care. Whether you're exploring options for managing treatment side effects, seeking to understand the current scientific evidence, or evaluating whether CBD or cannabis might be appropriate for your specific situation, the articles below represent the most current findings from credible research institutions and clinical trials.